March 18, 2023
Tag: Bladder Cancer Clinical Program

December 13, 2022
Bladder cancer: what patients need to know
Each year, nearly 75,000 people are diagnosed with bladder cancer. While more common in men over age 55, bladder cancer can—and does—affect women and men of all ages. Hear from our bladder cancer specialists to learn what newly diagnosed patients and their loved ones should know about bladder cancer.
November 30, 2022
Precision Oncology News: Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies

November 14, 2022
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.

January 26, 2022
Urologic oncologist makes his mark through robotic surgery program
Marc Bjurlin, DO, MSc, FACOS, specializes in minimally invasive techniques in cancer surgery and brings his expertise to the single port robotic surgery program.

August 30, 2021
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.

August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.

July 27, 2021
Patients with advanced bladder cancer could benefit from immunotherapy regardless of gene mutation status
Led by William Kim, MD, and colleagues, this research has important implications for patients who have not been offered immunotherapy because of their genetic profiles.

July 8, 2020
Patient a friend to others on bladder cancer journey
Over the years, Linda Willey has helped others going through cancer treatment. After treatment for her own cancer, she continues to connect with and support cancer patients.

April 6, 2020
Milowsky, Osterman published in the journal Cancer
Matthew Milowsky, MD, co-wrote an editorial on efforts to optimize a new precision medicine approach for treating metastatic urothelial carcinoma.